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Abstract Diamine oxidase (DAO) administration has been proposed to treat certain gastrointesti-
nal dysfunctions induced by histamine, an immunomodulator, signaling, and pro-inflammatory
factor. However, H2O2 resulting from the oxidative deamination of histamine byDAOmay be toxic.
The purpose of this study was to investigate to which extent DAO from white pea (Lathyrus
sativus), alone or in combination with catalase, may modulate histamine toxicity in the human
intestinal Caco-2 cell line. The results show that histamine at concentrations higher than 1 mM is
toxic to the Caco-2 cells, independently of the cell differentiation status, with a LC50 of ≅ 10 mM
following a 24-h exposure. Depending on its concentration, DAO increased histamine toxicity to a
greater extent in differentiated cells compared to undifferentiated cultures. In the presence of
catalase, the DAO-induced increase in histamine toxicity was completely abolished in the undiffer-
entiated cells and only partially decreased in differentiated cells, showing differences in the
sensitivity of Caco-2 cells to the products resulting from histamine degradation by DAO (H2O2,
NH3, or imidazole aldehyde). It appears that treatment of food histaminosis using a combination of
vegetal DAO and catalase would protect against histamine toxicity and prevent H2O2-induced
damage that may occur during histamine oxidative deamination.
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DMEM Dulbecco’s modified Eagle essential medium
MTT 3-[4,5-Dimethyl-2-thiazol-2-yl]-2,5-diphenyltetrazolium bromide
FBS Fetal bovine serum
LC50 Lethal concentration leading to 50% mortality
Introduction
Food histaminosis, associated with pseudo allergic phenomena, may occur upon ingestion of
histamine-containing foods, such as red wine, beer, chocolate, sauerkraut, fish, and processed
meats. Histaminosis is an enteric dysfunction that often affects the population in industrialized
countries. This disorder is more frequent in people with low level of intestinal histaminase [1, 2],
a copper-containing diamine oxidase (DAO, EC 1.4.3.22) able to catalyze the oxidative
decomposition of histamine and producing H2O2, NH3, and imidazole acetaldehyde. The
sensitivity to histamine is associated to symptoms such as gastro-intestinal discomfort [3, 4],
migraine [5], irritation of nasal mucosa, itching, and other forms of allergy [6]. In addition,
histamine, also known as a pro-inflammatory agent, is a risk factor for subjects suffering from
inflammatory bowel diseases (IBDs) and colon cancer [7]. Furthermore, lowered activity of
histamine catabolism has been shown in colonic mucosa of patients with colonic adenomas [8].
No pharmaceutical treatment is currently available to control the level of intestinal histamine.
In this context, considering that the intestinal DAO is the main enzyme metabolizing ingested
histamine [9], DAO supplements orally administered have been suggested for the treatment of
food histaminosis and other dysfunctions related to impaired histamine metabolism. A com-
mercial form of pig kidney DAO is available under different brand names as a food supplement
(but not as pharmaceutical agent) aimed to break down food histamine in the digestive tract [1,
10, 11]. An oral form of a vegetal DAO, formulated as monolithic tablets with a carboxymethyl
starch (CM-starch) excipient, was proposed to target the lower intestinal tract and to decrease the
inflammation (i.e., Crohn’s disease, ulcerative colitis) [12].
However, considering that not only histamine as a substrate but also the products of DAO
catalytic activity, especially H2O2, may be toxic to the cell, the aim of the study was to analyze
the effect of histamine and of vegetal DAO activity on the viability of the human intestinal cells
Caco-2. The effects of histamine-related molecules, such as histidine (precursor of histamine)
and imidazole, were also investigated. Vegetal DAO was chosen for its much higher specific
activity compared to that of animal DAO (i.e., pig kidney) [13–15] and also because enzymes
from vegetal sources are more accepted by regulatory affairs. Histaminase was used alone or in
combination with CAT. The rationale of using DAO in combination with catalase relies on the
ability of CAT to decompose H2O2 into O2 and H2O. The investigation was conducted on
undifferentiated (7-day-old) and differentiated (21-day-old) Caco-2 cell cultures. This cell line is
widely used as an in vitro model to study intestinal function because it undergoes enterocytic
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differentiation spontaneously. An exponential growth phase is observed until dish culture
confluence is reached (around day 7). Then, a stationary growth phase is observed and cells
develop functional (i.e., transport mechanisms, enzymes) as well as morphological (microvilli)
features of mature enterocytes [16, 17]. The level of differentiation increases up to 3 weeks of
culture [18], and monolayers are homogenously polarized and differentiated by 4 weeks [19].
Material and Methods
Chemicals
Histamine, histidine, imidazole, hydrogen peroxide, o-phthaldialdehyde (OPT), 4-
aminoantipyrine (APP), 3,5-dichloro-2-hydroxybenzensulfonic acid (DCHBS), xanthine, pyro-
gallol, putrescine dihydrochloride (PUT), D-glucose, glutamine, bovine liver catalase (9803 U/
mg solid), horseradish peroxidase (HRP), butter milk xanthine oxidase, cytochrome c, bovine
serum albumin, nonessential amino acids, penicillin–streptomycin, trypsin, EDTA, and 3-[4,5-
dimethyl-2-thiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) were from Sigma-Aldrich Co
(St. Louis, MO, USA). Fetal bovine serum (FBS) was purchased from Wisent Inc. (St-Bruno,
QC, Canada). Dulbecco’s Modified Eagle minimum essential medium (DMEM) with high
glucose (25 mM) was from Gibco Life Technologies, Co (Grand Island, NY, USA). Other
chemical reagents were of ACS grade and used without further purification.
Preparation and Characterization of DAO from Lathyrus sativus Seedlings
Diamine oxidase was prepared as previously reported by homogenizing Lathyrus sativus
seedlings in 50mMphosphate buffer (pH 5.5) containing 200mMNaCl [20]. After preparation,
samples were lyophilized and stored at −20 °C until use. All the preparations were characterized
for DAO activity as well as for the presence of contamination-related enzymes that may modify
the level of H2O2, namely, catalase (CAT), peroxidase (POD), and superoxide dismutase (SOD).
Separately, some DAO preparations were treated with sodium azide in order to inhibit traces of
CAT and POD: DAO at a concentration of 19.8 mg powder per milliliter were incubated with
0.2 mg/mL sodium azide at 37 °C for 200 min in 50 mM phosphate buffer, pH 7.4.
Diamine oxidase activity was assayed at 25 °C with 3 mM putrescine in 0.1 M potassium
phosphate buffer (pH 7.4) by measuring the rate of H2O2 production that forms pink
adducts (ε 515 nm = 2.6 × 10
4 M−1 cm−1) with 2 mM 4-aminoantipyrine (APP) in the
presence of horseradish peroxidase (HRP) (10 U/mL) and of 4 mM 3,5-dichloro-2-
hydroxybenzensulfonic acid (DCHBS) medium [14]. One unit (U) of DAO oxidized 1 μmol of
putrescine per minute. Catalase activity was assayed by measuring the initial decrease in the
absorbance of a solution of 15mMH2O2 in 66mMphosphate buffer, pH 7 (ε240nm = 36M
−1 cm−1)
[21]. One unit of CAT decomposed 1 μmol of H
2
O2 per minute. Peroxidase activity was assayed at
25 °C in 14mMphosphate buffer, pH 6,with 40mMpyrogallol bymeasuring the production rate of
purpurogallin (ε420 nm for 0.1% purpurogallin solution = 12 cm
−1) in the presence of 8.6 mMH2O2
[22]. One unit of PODproduced 1mg of purpurogallin perminute. Protein content was estimated by
the Bio-Rad protein assay reagent using bovine serum albumin as the calibration standard.
Superoxide dismutase activity was assayed at 550 nm by measuring the reduction of 10 μM
cytochrome c by superoxide generated during the oxidation of 50mMxanthine by xanthine oxidase
[23]. One unit of SOD decreased the rate of cytochrome c reduction by 50%.
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LyophilizedDAO samples contained 0.38 ± 0.02mg protein/mg solid, 12.25 ± 4.92UDAO/mg
solid, 1.32 ± 0.97UCAT/mg solid, 0.93 ± 0.20UPOD/mg solid, and 13.9 ± 2.03USOD/mg solid.
Measurement of Histamine Degradation and H2O2 Production
Kinetic studies of histamine degradation and H2O2 production resulting from the oxidative
deamination of histamine by DAO were performed at 37 °C in Dulbecco’s modified Eagle
essential minimummedium (DMEM) by incubating 2.75 or 8.5mMhistamine with 0.77, 4.62, or
9.40 mg solid/mL DAO, in the absence or presence of CAT (2941 U/mL). Histamine concentra-
tion was estimated by a modified spectrofluorimetric method (λex = 360 nm; λem = 450 nm) [24].
Briefly, at intervals of time, 10-μL aliquots of the incubation mixture were withdrawn and added
to 0.290mL 0.1MHCl to stop the oxidative deamination of histamine. Samples were then diluted
50 or 133 times in 2 mL 0.1 M HCl. Then, 80 μL of 5 M NaOH and 10 μL of 0.5% w/v o-
phthaldialdehyde (OPT) were added. Samples were incubated at room temperature for 4 min, and
the reaction was stopped with 200 μL of 3 MHCl. The concentration of histamine was estimated
according to a standard curve established under the same experimental conditions.
To measure the rate of H2O2 production as a result of the oxidative deamination of histamine
by DAO, 5- or 10-μL aliquots of the incubation mixture were withdrawn, added to 30 μL of a
solution containing 0.8 M bromoethylamine and 25 mg/mL sodium azide and incubated at room
temperature for 15min to inhibit DAO, CAT, and POD activities. Samples were further diluted 30
times in the APP/DCHBS/HRP medium described above and incubated for 3 min at room
temperature. The absorbance was then read at 515 nm, subtracted from the baseline absorbance
(650 nm), and the concentration of H2O2 was estimated (ε240nm = 36 M
−1 cm−1).
Cell Culture
The Caco-2 cell line (passages 207 to 255), obtained from Dr. A Zweibaum [16, 17], was
maintained in DMEM containing 25 mM glucose and supplemented with 15% inactivated
(56 °C for 30 min) fetal bovine serum (FBS), 0.1 mM nonessential amino acids, and 50 U/mL–
50μg/mL penicillin–streptomycin. Stock cultureswere seeded in 75-cm2 culture flasks at 37 °C in a
5% CO2–95% humidified air atmosphere and were passaged weekly by trypsinization (0.05%
trypsin–0.053 mM EDTA). For all the experiments, cells were seeded in 96-well plates (5 × 103/
well). The culture mediumwas changed every 2 days, and cells were maintained for 7 or 21 days in
order to study early confluent but undifferentiated cell cultures and well-differentiated cells,
respectively [18].
Cell Viability Measurement
Cell viabilitywasmeasured by theMTTcolorimetric assay, whichmeasuresMTTreduction to a blue
formazan product by dehydrogenases of viable cells [25]. Cells were rinsed twice with DMEMFBS-
free culture medium prior to a 24-h incubation in the presence of histamine, histidine, imidazole, or
mixtures of histamine (2.75 or 8.5 mM) and DAO (0.77, 4.62, or 9.40 mg solid/mL) in the presence
or in the absence of 0.77 mg solid/mL CAT in DMEM FBS-free medium. At the end of the
incubation period, MTT was added to each well at a final concentration of 1.2 mM (0.5 mg/mL).
Cells were incubated for 2 h at 37 °C, themediumwas removed, and 0.2mL ofDMSOwas added to
dissolve the formazan crystals. Optical density at 575 nm was measured using a Tecan SpectraFluor
Plus microplate spectrophotometer (Esbe Scientific Industries Inc., Canada).
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Results
Kinetic of H2O2 Production in FBS-Free DMEM Medium
Time-course of histamine consumption upon addition of DAO isolated from Lathyrus sativus
in FBS-free DMEM well fitted a first-order decay equation (Y = Ymax × e
−kt) allowing the
estimation of the rate constants of consumption (k) and t1/2 values (ln2/k) representing time for
which degradation is half-completed (Fig. 1, circles). As expected, t1/2 values decreased with
increasing [DAO]/[histamine] ratios (Table 1). On the basis of a stoichiometry of 1:1 for
histamine oxidation and H2O2 production, the expected time-course of theoretical production
of H2O2 (Fig. 1, squares) was compared to measured H2O2 contents (Fig. 1, triangles). It was















































































































Fig. 1 Level of histamine (circles) and of expected (squares) and measured (triangles) H2O2 in serum-free
DMEM medium as a function of time in the presence of 0.77 mg solid per milliliter (A, B), 4.62 mg solid per
milliliter (C, D), 9.40 mg solid per milliliter (E, F) DAO and 2.75 (A, C, E) or 8.5 mM (B, D, F) histamine.
Inserts for C, E, F show continuing time-courses for the first 60 min. Data shown are means ± SD estimated on
four different experime
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quite apparent that H2O2 accumulation was much lower than predicted (half to only 1/10 of the
theoretical level). Moreover, in the presence of 4.62 mg/mL (Fig. 1c, d) and 9.40 mg/mL DAO
(Fig. 1e, f), H2O2 generated within the first 5–20 min almost disappeared after 50–100 min.
However, with DAO samples pretreated with sodium azide (that inhibits catalase but not amine
oxidase activity), the measured and predicted levels of H2O2 were not significantly different
(data not shown). Thus, some contamination-related activity of CAT in DAO preparations
may be responsible for the progressive degradation of generated H2O2. As far as the rate of
NH3 accumulation is concerned, it was reversely related to the rate of histamine consumption,
as expected (data not shown).
In order to completely remove H2O2 generated during histamine deamination by DAO, addi-
tional CATwas used in combination with DAO. Concentrations of CAT higher than of 200 U/mL
eliminated H2O2 under our experimental conditions (data not shown). For safety and to ensure
complete elimination, CAT at a concentration of 7528 U/mL was used for cell treatments.
Effect of Vegetal DAO on Histamine Cytotoxicity
When the Caco-2 cells were exposed to histamine, typical concentration-response curves of
BMTT activity^ were obtained as a function of increasing concentrations of histamine with
LC50 (histamine concentration for which cell viability is half the control value) of
8.5 ± 0.9 mM on day 7 of culture and 11.8 ± 3.4 mM on day 21 of culture (Fig. 2a). Histidine
did not affect cell viability up to 1 mM, and a 50% increase in BMTTactivity^ was measured at
higher concentrations up to 30 mM (Fig. 2b). Imidazole up to 10 mM did not affect cell
viability whereas a 30% decrease was obtained at 30 mM (Fig. 2c) with no significant
difference between undifferentiated and differentiated cells.
Table 1 Time-course of histamine degradation expressed as t1/2 ± SER values (min) estimated by nonlinear
regression analysis according to the equation of first-order rate decay (Fig. 1): Y = Ymax × e
−kt where t1/2 = ln2/k
and k = rate constant of histamine consumption
Histamine Vegetal DAO
0.77 mg/mL 4.62 mg/mL 9.40 mg/mL
2.75 mM 18.6 ± 1.2 5.2 ± 1.0 4.3 ± 0.4
8.50 mM 68.3 ± 6.0 19.9 ± 4.5 6.8 ± 0.5


















































Fig. 2 MTT activity concentration-response curve as a function of increasing concentration of histamine (a),
histidine (b), and imidazole (c). Caco-2 cells were cultured in the presence of FBS for 7 (open circles) or 21 days
(filled circles) and were then exposed to compounds for 24 h in the absence of FBS. Data shown are mean ± SD
estimated on three to five independent cell cultures
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The effect of the vegetal DAO on histamine toxicity was studied for 2.75 and 8.5 mM
histamine which led to 25 and 50% mortality, respectively (Fig. 2a). Diamine oxidase at a
concentration of 0.77 mg solid/mL significantly increased the toxicity of 2.75 or 8.5 mM
histamine, lowering cell viability to about 32–38% in 7-day-old cells (Fig. 3a, c, filled circles).
This effect was less evident in the presence of 4.62 mg solid per milliliter of DAO, and it did
not occur at a DAO concentration of 9.24 mg solid per milliliter.
Similar results were obtained in 21-day-old cells exposed to 2.75 mM histamine, whereas in
cells treated with 8.5 mM histamine, the same level of mortality was obtained, regardless of the
DAO concentration (Fig. 3b, d, filled circles). The greater protection observed at higher DAO
concentrations can be explained by the faster rate of histamine decomposition, which depends
on DAO content and also by the faster H2O2 removal due to the presence of higher levels of
contaminating CAT (i.e., 1.02, 6.10, and 12.20 U CAT for 0.77, 4.62, and 9.24 mg/mL DAO,
respectively).
In all cases, the addition of exogenous CATat a concentration of 0.77 mg solid per milliliter
(7548 U/mL) efficiently protected the cells against DAO-induced histamine toxicity (Fig. 3,
open squares). The protective effect of CAT was very strong in 7-day-old cells, where it
efficiently decreased not only the DAO-dependent histamine toxicity but also the toxicity of
histamine per se.
To better understand the effect of combinations of DAO and CAT on histamine cyto-
toxicity, parallel experiments were conducted to get information on the cells’ response to
the products resulting from a 24-h deamination of histamine: (1) when histamine was added
to cells after a 10-min pretreatment with DAO (with or without CAT) and (2) when DAO
was first preincubated with histamine (with or without CAT) in the absence of cells,
followed by incubation with the cells (Fig. 4). In 7-day-old cultures, the presence of CAT
afforded protection from the damage induced by 0.77 mg/mL DAO plus histamine,
























































































Fig. 3 Effect of DAO and histamine on viability of cells, expressed as MTT activity. Cells were cultured in the
presence of FBS for 7 (a, b) or 21 days (c, d) and were then exposed for 24 h to various concentrations of DAO
and 2.75 (a, c) or 8.5 mM (b, d) histamine with (open squares) or without (filled circles) 0.77 mg solid/mL
catalase in the absence of FBS. Data shown are mean ± SD estimated on six to seven independent cell cultures
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irrespective of the exposure protocol or the histamine concentration. However, in 21-day-
old cells, the protective effect of CAT was slightly lower than in 7-day-old cells, in
accordance with the moderately lower protection provided by CAT at higher levels of
histamine (Fig. 3).
Discussion
Immunomodulators and signaling and pro-inflammatory agents such as histamine are well
recognized among the causative factors of intestinal inflammatory conditions and related
colorectal cancer incidence. Different histamine antagonists are commercially available, but
none of them effectively acts on the intestine. In contrast, vegetal DAOhas been suggested as an
efficient therapeutic enzyme able to metabolize histamine and evidence has been provided that
it can control histamine level in different organs including the small intestine [26]. However, the
catalytic activity of DAO on histamine results in the generation of toxic products such as H2O2,
NH3, and imidazole acetaldehyde. Among these products, H2O2, a potent pro-oxidant, is
particularly toxic, and for this reason we have suggested DAO in combination with CAT as
therapeutic enzymes to improve the therapy of IBD and to prevent the colorectal cancer.
Histamine was found to be similarly toxic to the Caco-2 cells, independent of the differ-
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Fig. 4 Effect of DAO and
histamine on MTT activity as
value of cell viability. Cells were
cultured in the presence of FBS for
7 (a) or 21 days (b) and were then
exposed for 24 h to 2.75 or
8.5 mM histamine, alone (black
columns) or in the presence of
0.77 mg/mL DAO with or without
0.77 mg/mL catalase. Cells were
exposed to DAO (± CAT) 10 min
prior to the addition of histamine
or were exposed to a mixture of
DAO and histamine (with and
without catalase) preincubated for
2 h at 37 °C before use for cell
treatment. Data shown are mean ±
SD estimated on three to six
independent cell cultures. Columns
labeled with different letters are
significantly different (p ≤ 0.05)
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of histamine, did not affect cell viability and even induced a 50% increase in BMTTactivity^ at
concentrations higher than 1 and 30 mM in 7- and 21-day-old cells, respectively (Fig. 2b).
MTT assay is widely used in cytotoxicity studies as well as for measuring cell proliferation.
However, it was previously shown that an increase in BMTT activity^ does not necessarily
mean cell proliferation [27–29]. Additional experiments will be required to elucidate whether
higher BMTT activity^ is related to a real increase of cell proliferation or solely to an increase
of cellular dehydrogenase activities. Interestingly, [3H]-thymidine incorporation measurements
have revealed that much lower levels of histamine (1 μM) would stimulate Caco-2 cell
proliferation [30], whereas colorimetric measurements similar to the MTT assay failed to
demonstrate a proliferative effect [31]. Imidazole, the aromatic ring of histamine, did not
significantly affect cell viability, but higher concentrations should be tested as a downward
trend in MTT reduction was observed for levels higher than 30 mM, especially in differenti-
ated cells (Fig. 2c).
Although a similar sensitivity to histamine was obtained regardless of the cell growth
stage, the differentiated 21-day-old cells were more sensitive to histamine in the presence
of DAO than the undifferentiated 7-day-old cells (Figs. 3 and 4). Moreover, whatever the
concentration of histamine, CAT provided a higher level of protection in undifferentiated
cells, whereas the protection was less important in differentiated cells. These data may
suggest that by-products, other than H2O2, could be responsible for the observed differ-
ences in cell sensitivity. Thus, the responsiveness of the Caco-2 cells to imidazole
acetaldehyde or ammonia, generated during the oxidative deamination of histamine,
may vary with the differentiation status. However, higher levels of cellular antioxidant
enzymatic activities (including CAT) have been suggested in differentiated Caco-2 cells
[32]. Alternatively, differences in sensitivity to mixtures of histamine and DAO may be
related to various levels of expression of endogenous DAO. Indeed, DAO does not seem
to be involved in the enterocytic differentiation of the Caco-2 cells [33], but the level of
DAO expression in these cells increases during the differentiation process [34]. More-
over, such as in the intestinal mucosa in vivo, significant DAO secretion is observed with
differentiated Caco-2 cells [35]. Though this secretion would mainly occur through the
basolateral side of the cell membrane (which is optimized in filter-grown cultures), some
lateral secretion of endogenous DAO from cells grown on Petri dishes cannot be
excluded. This additional extracellular DAO would lead to higher levels of H2O2 pro-
duction in the culture medium of differentiated cells compared to undifferentiated cells
during exposure to histamine. Moreover, and contrary to vegetal DAO, the DAO secreted
from cells is not expected to be Bcontaminated^ with CAT.
The higher toxicity of histamine obtained with 0.77 mg solid per milliliter of DAO compared
to 4.62 and 9.40 mg solid/mLDAO is in agreement with the time-course data of H2O2 production
(Fig. 1). Indeed, 1.1 and 4.2 mM H2O2 were still measured in the medium at the end of the 24-h
incubation period with 2.75 and 8.5 mM histamine, respectively, whereas no significant levels of
H2O2 could be detected in the medium after 2 h of exposure to higher DAO concentrations.
Accordingly, 4.62 and 9.40 mg solid/mL DAO did not significantly increase histamine toxicity
and cell viability was comparable to that measured in the presence of histamine alone, especially
in undifferentiated cells (Fig. 3). Thus, deamination of histamine with low DAO produced higher
and more sustained levels of H2O2 compared to high concentrations of DAO. Data obtained with
the sodium azide-pretreated enzyme suggest that the rapid disappearance of H2O2 with high
concentrations of DAO may be related to CAT contaminating DAO preparations, which in fact
provides some protection against H2O2 toxicity.
Appl Biochem Biotechnol
The present data suggest that the combination of DAO with CAT has great potential to
control the biological effect of histamine. Considering the turnover number of the two
enzymes, appropriate concentrations are required for a fast removal of histamine without
accumulation of H2O2. The presence of CAT not only promotes the clearance of toxic H2O2
but, by releasing oxygen, also favors the shift of equilibrium toward histamine decomposition
in the DAO-catalyzed reaction.
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